Related Experiment Videos
T-cell receptor alpha/beta chain-CD3 protein complex defect in systemic lupus erythematosus: T-cell function
S Raziuddin1, M A al-Janadi, A A Alwabel
1Department of Clinical Immunology, King Saud University, College of Medicine, Abha, Saudi Arabia.
The American Journal of Medicine
|October 1, 1992
Summary
This study details a unique case of systemic lupus erythematosus (SLE) with T cells lacking T-cell receptor alpha/beta and CD3 expression. This defect impairs T-cell function but reveals independent regulation of lymphokine secretion in SLE patients.
Area of Science:
- Immunology
- Cell Biology
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune system dysregulation.
- T-cell receptor (TcR) alpha/beta and CD3 protein coexpression are critical for T-cell antigen recognition and function.
Observation:
- A rare SLE case presented with peripheral blood T cells deficient in cell surface TcR alpha/beta and CD3 expression.
- Functional assays revealed significantly reduced T-cell proliferation in response to anti-CD3 antibody and mitogens.
- Interleukin-2 (IL-2) secretion was deficient, and mixed lymphocyte reactions showed impaired T-cell responses.
Findings:
- Despite TcR alpha/beta/CD3 deficiency, T-cell helper-inducer function remained intact.
- An increase in CD4+ CDw29+ helper-inducer T cells correlated with elevated B-cell growth factor (BCGF) and B-cell differentiation factor (BCDF) secretion.
- These findings suggest independent regulation of IL-2, BCGF, and BCDF secretion pathways in T cells.
Implications:
- This case highlights a unique T-cell defect associated with SLE pathology.
- The independent control of lymphokine secretion pathways offers new insights into immune regulation in autoimmune diseases.
- Understanding these specific T-cell defects could lead to targeted therapies for SLE and related conditions.